NO963792L - Piperazinderivater, fremgangsmåter for fremstilling samt preparater inneholdende slike - Google Patents

Piperazinderivater, fremgangsmåter for fremstilling samt preparater inneholdende slike

Info

Publication number
NO963792L
NO963792L NO963792A NO963792A NO963792L NO 963792 L NO963792 L NO 963792L NO 963792 A NO963792 A NO 963792A NO 963792 A NO963792 A NO 963792A NO 963792 L NO963792 L NO 963792L
Authority
NO
Norway
Prior art keywords
preparation
methods
preparations containing
piperazine derivatives
piperazine
Prior art date
Application number
NO963792A
Other languages
English (en)
Other versions
NO307459B1 (no
NO963792D0 (no
Inventor
Eui-Hwan Cho
Sun-Gan Chung
Joong-Young Kim
Sun-Hwan Lee
Ho-Seok Kwon
Byung-Chul Kim
Jae-Myeong Kong
Jae-Eung Lee
Dong-Wook Kang
Original Assignee
Samjin Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019950043607A external-priority patent/KR0162710B1/ko
Application filed by Samjin Pharm Co Ltd filed Critical Samjin Pharm Co Ltd
Publication of NO963792D0 publication Critical patent/NO963792D0/no
Publication of NO963792L publication Critical patent/NO963792L/no
Publication of NO307459B1 publication Critical patent/NO307459B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
NO963792A 1995-01-11 1996-09-10 Piperazinderivater, samt farmasøytiske preparater inneholdende slike NO307459B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19950000399 1995-01-11
KR1019950043607A KR0162710B1 (ko) 1995-01-10 1995-11-24 신규 피페라진 유도체 및 그 제조방법
PCT/KR1996/000005 WO1996021648A1 (en) 1995-01-11 1996-01-10 New piperazine derivatives and methods for the preparation thereof and compositions containing the same

Publications (3)

Publication Number Publication Date
NO963792D0 NO963792D0 (no) 1996-09-10
NO963792L true NO963792L (no) 1996-11-11
NO307459B1 NO307459B1 (no) 2000-04-10

Family

ID=26630862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963792A NO307459B1 (no) 1995-01-11 1996-09-10 Piperazinderivater, samt farmasøytiske preparater inneholdende slike

Country Status (16)

Country Link
US (1) US5780472A (no)
EP (1) EP0749425A1 (no)
JP (1) JP2978967B2 (no)
CN (1) CN1128139C (no)
AU (1) AU699619B2 (no)
BR (1) BR9605309A (no)
CA (1) CA2184919C (no)
CZ (1) CZ288002B6 (no)
FI (1) FI963566A (no)
HU (1) HUP9602489A3 (no)
NO (1) NO307459B1 (no)
NZ (1) NZ298499A (no)
PL (1) PL183865B1 (no)
RO (1) RO115159B1 (no)
SK (1) SK282252B6 (no)
WO (1) WO1996021648A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE294778T1 (de) * 1995-01-23 2005-05-15 Daiichi Suntory Pharma Co Ltd Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen
DE69722360T2 (de) * 1996-06-29 2003-11-27 Samjin Pharm, Co. Piperazin-derivate und verfahren zu ihrer herstellung
US6174905B1 (en) 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
US6794392B1 (en) 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
KR100420616B1 (ko) * 1996-12-26 2004-05-17 동화약품공업주식회사 신규테레프탈산아미드유도체
AU754529B2 (en) 1998-09-22 2002-11-21 Yamanouchi Pharmaceutical Co., Ltd. Cyanophenyl derivatives
CN100354271C (zh) * 1999-03-03 2007-12-12 三进制药株式会社 哌嗪衍生物及其制备方法
MXPA03000458A (es) 2000-07-20 2004-06-02 Neurogen Corp Ligandos receptores de capsaicina.
DE10035908A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
US6432957B1 (en) * 2001-06-29 2002-08-13 Kowa Co., Ltd. Piperazine derivative
JP2005502623A (ja) * 2001-07-02 2005-01-27 ノボ ノルディスク アクティーゼルスカブ 置換ピペラジンおよびジアゼパン
CA2463272C (en) * 2001-10-22 2009-11-17 Laura Cook Blumberg Piperazine derivatives with ccr1 receptor antagonist activity
AU2002351731A1 (en) * 2001-12-14 2003-06-30 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
WO2003066595A2 (en) 2002-02-01 2003-08-14 Euro-Celtique S.A. 2 - piperazine - pyridines useful for treating pain
US7279493B2 (en) 2002-06-28 2007-10-09 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7262194B2 (en) 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7157462B2 (en) 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US8013156B2 (en) * 2003-03-19 2011-09-06 Exelixis, Inc. Tie-2 modulators and methods of use
UA89514C2 (uk) * 2004-12-30 2010-02-10 Janssen Pharmaceutica Nv Похідні феніламідів 4-(бензил)-піперазин-1-карбонових кислот та споріднені сполуки як модулятори гідролази амідів жирних кислот для лікування тривоги, болю та інших станів
ES2528674T3 (es) 2005-02-17 2015-02-11 Astellas Pharma Inc. Piperidina y carboxilatos de piperacina como inhibidores de FAAH
WO2007005510A1 (en) 2005-06-30 2007-01-11 Janssen Pharmaceutica N.V. N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
US7812025B2 (en) 2005-08-12 2010-10-12 Takeda Pharmaceutical Company Limited Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder
KR101181194B1 (ko) 2006-10-18 2012-09-18 화이자 프로덕츠 인코포레이티드 바이아릴 에터 우레아 화합물
AU2008258487B2 (en) * 2007-06-08 2012-11-15 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
JP5464709B2 (ja) 2007-06-08 2014-04-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピペリジン/ピペラジン誘導体
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
CA2687912C (en) 2007-06-08 2015-11-03 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
EA201070451A1 (ru) * 2007-10-10 2010-10-29 Такеда Фармасьютикал Компани Лимитед Амидные соединения
AU2009253892B2 (en) 2008-06-05 2015-07-30 Janssen Pharmaceutica Nv Drug combinations comprising a DGAT inhibitor and a PPAR-agonist
WO2011060026A1 (en) 2009-11-12 2011-05-19 Jansen Pharmaceutica Nv Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
UA108233C2 (uk) * 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
WO2017083216A1 (en) * 2015-11-12 2017-05-18 Merck Sharp & Dohme Corp. Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use
WO2018081167A1 (en) * 2016-10-24 2018-05-03 Yumanity Therapeutics Compounds and uses thereof
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
CA3127791A1 (en) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Compounds and uses thereof
JPWO2022118966A1 (no) * 2020-12-04 2022-06-09

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.
WO1987007895A1 (en) * 1986-06-23 1987-12-30 The Upjohn Company Androstane-type and cortical aminoesters
US4960776A (en) * 1987-01-28 1990-10-02 A. H. Robins Company, Inc. 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
JPH02142770A (ja) * 1988-11-25 1990-05-31 Shigeki Shin ピペラジン系誘導体
JPH03141258A (ja) * 1989-10-25 1991-06-17 Kowa Co 新規なピペラジン誘導体
DE4216364A1 (de) * 1991-12-14 1993-11-25 Thomae Gmbh Dr K Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas

Also Published As

Publication number Publication date
CA2184919C (en) 2000-03-14
HU9602489D0 (en) 1996-11-28
HUP9602489A3 (en) 1998-01-28
SK88996A3 (en) 1997-05-07
FI963566A0 (fi) 1996-09-10
WO1996021648A1 (en) 1996-07-18
JPH09511764A (ja) 1997-11-25
JP2978967B2 (ja) 1999-11-15
PL183865B1 (pl) 2002-07-31
PL316613A1 (en) 1997-01-20
AU4400796A (en) 1996-07-31
CN1128139C (zh) 2003-11-19
CZ288002B6 (cs) 2001-03-14
BR9605309A (pt) 1997-10-14
CZ296096A3 (en) 1997-02-12
NO307459B1 (no) 2000-04-10
FI963566A (fi) 1996-09-10
AU699619B2 (en) 1998-12-10
SK282252B6 (sk) 2001-12-03
EP0749425A1 (en) 1996-12-27
HUP9602489A2 (en) 1997-08-28
NZ298499A (en) 1998-01-26
US5780472A (en) 1998-07-14
NO963792D0 (no) 1996-09-10
CA2184919A1 (en) 1996-07-18
RO115159B1 (ro) 1999-11-30
CN1145620A (zh) 1997-03-19

Similar Documents

Publication Publication Date Title
NO963792D0 (no) Piperazinderivater, fremgangsmåter for fremstilling samt preparater inneholdende slike
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK0918059T3 (da) Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
NL970020I2 (nl) Cinolinederivaten en werkwijzen voor de bereiding daarvan.
FI973278A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO972881D0 (no) Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling
PL311999A1 (en) Piperazine derivatives, therapeutic agents containing them and method of obtaining such derivatives
HUP9603071A2 (en) Purin-6-one derivatives and pharmaceuticals preparations containing them
DK85087A (da) Substituerede thienoimidazol-derivater, deres fremstilling, praeparater, indeholdende disse, samt anvendelse deraf
NO932120D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
DK219387A (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
DK0562583T3 (da) Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf
KR970000228A (ko) S-에토돌락의 경구용 제제
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
IL90007A0 (en) N-alkoxy-alkylamido derivatives,methods for the preparation thereof and cosmetic preparations containing the same
DK642588D0 (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NO931527D0 (no) Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling
NO169339C (no) Derivater av 4-hydroksy-2h-1-benzotiopyran-2-on, samt rottegiftpreparat hvor slike derivater inngaar
EE9400148A (et) Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid
NO305750B1 (no) Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene
DK135789A (da) 19-thiosubstituerede delta4-androstenderivater samt farmaceutisk praeparat indeholdende disse